Literature DB >> 11756598

Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation.

H Miyajima1, S Kono, Y Takahashi, M Sugimoto, M Sakamoto, N Sakai.   

Abstract

BACKGROUND: Aceruloplasminemia, an autosomal recessive disorder that affects human iron metabolism, is caused by mutation of the ceruloplasmin gene. Heterozygous individuals with a partial ceruloplasmin deficiency may have normal iron metabolism and no clinical symptoms.
METHODS: The authors clinically characterized three Japanese patients from two families who had cerebellar ataxia with hypoceruloplasminemia from the fourth decade of life. Genetic analysis, restriction fragment length polymorphism analysis, and a pathologic study were performed.
RESULTS: All three patients presented with cerebellar dysfunction that included relatively nondisabling gait ataxia and dysarthria, as well as hyperreflexia. Brain and abdomen MRI showed cerebellar atrophy and no low-signal intensities in the basal ganglia, thalamus, and liver. Direct mutational analysis excluded SCA-1, SCA-2, SCA-3, SCA-6, SCA-7, SCA-8, SCA-12, and DRPLA. The patients partially lacked serum ceruloplasmin, and the protein concentrations and ferroxidase activities ranged from 36% to 41% of the control values; moreover, they were heterozygous for a nonsense mutation of the ceruloplasmin gene (Trp858ter). Serum iron concentration and transferrin saturation were normal. At autopsy, pathologic and biochemical examinations showed marked loss of Purkinje cells, a large iron deposition in the cerebellum, and small depositions in the basal ganglia, thalamus, and liver.
CONCLUSION: Cerebellar ataxia reflects the site of iron deposition. Being heterozygous for mutation of the ceruloplasmin gene may result in cerebellar ataxia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756598     DOI: 10.1212/wnl.57.12.2205

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation.

Authors:  Jens Kuhn; Hiroaki Miyajima; Yoshitomo Takahashi; Bernhard Kunath; Ursula Hartmann-Klosterkoetter; Déirdre Cooper-Mahkorn; Mark Schaefer; Heiko Bewermeyer
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

2.  Multiple motor system dysfunction associated with a heterozygous ceruloplasmin gene mutation.

Authors:  Adolfo Jiménez-Huete; Juan Bernar; Hiroaki Miyajima; Yoshitomo Takahashi; Juan Alvarez-Linera; Oriol Franch; Marjo S van der Knaap
Journal:  J Neurol       Date:  2008-02-25       Impact factor: 4.849

3.  Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson's disease.

Authors:  Na Zhao; Jianqiu Xiao; Zhiyong Zheng; Guoqiang Fei; Feng Zhang; Lirong Jin; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2015-03-10       Impact factor: 5.203

4.  Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease.

Authors:  Bakytzhan Bakhautdin; Maria Febbraio; Esen Goksoy; Carol A de la Motte; Muhammet F Gulen; Erin Patricia Childers; Stanley L Hazen; Xiaoxia Li; Paul L Fox
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

5.  Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.

Authors:  Satoshi Kono; Hitoshi Suzuki; Toshiaki Oda; Hiroaki Miyajima; Yoshitomo Takahashi; Kentaro Shirakawa; Kuniko Ishikawa; Masatoshi Kitagawa
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI.

Authors:  Matthias Maschke; Johannes Weber; Udo Bonnet; Albena Dimitrova; Julia Bohrenkämper; Sonja Sturm; Bernhard W Müller; Markus Gastpar; Hans-Christopher Diener; Michael Forsting; Dagmar Timmann
Journal:  J Neurol       Date:  2005-03-23       Impact factor: 4.849

7.  MR imaging of cerebral cortical involvement in aceruloplasminemia.

Authors:  Marina Grisoli; Alberto Piperno; Luisa Chiapparini; Raffaella Mariani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

8.  Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

Authors:  R Mariani; C Arosio; S Pelucchi; M Grisoli; A Piga; P Trombini; A Piperno
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Perinatal copper deficiency alters rat cerebellar purkinje cell size and distribution.

Authors:  Jacob A Lyons; Joseph R Prohaska
Journal:  Cerebellum       Date:  2010-03       Impact factor: 3.847

10.  Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.

Authors:  Matthew A Stroh; Michelle K Winter; Russell H Swerdlow; Kenneth E McCarson; Hao Zhu
Journal:  Metab Brain Dis       Date:  2016-05-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.